Literature DB >> 7177168

Monoclonal antibodies recognizing determinants specific for the promastigote state of Leishmania mexicana.

D M Pratt, J R David.   

Abstract

Two monoclonal antibodies (IX-IF9-D8 and IX-5H9=C1) produced to a membrane enriched fraction of Leishmania mexicana amazonensis promastigotes have been demonstrated to be specific for the promastigote (insect) form and not the amastigote (mammalian host) form of the parasite. The antigens recognized by these monoclonal antibodies are not found on amastigotes isolated from infected animals or on amastigotes isolated from a macrophage cell line J774 infected initially with promastigotes. The antigens are not re-expressed by amastigotes cultured at 34 degrees C; however, amastigotes cultured at 24 degrees C that have begun transformation into promastigotes do express these antigens. The level of expression of these antigens in cultures of amastigotes undergoing transformation into promastigotes, increases with time from 16 to 36 h and appears to correlate with the percentage of promastigotes. Two protein molecules with apparent molecular weights of 40,000 and 92,000 have been identified by radioimmune precipitation as associated with L. mexicana promastigote stage specific determinants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7177168     DOI: 10.1016/0166-6851(82)90064-0

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  5 in total

1.  Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes.

Authors:  J H LeBowitz; C M Coburn; D McMahon-Pratt; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

3.  Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection.

Authors:  D McMahon-Pratt; D Rodriguez; J R Rodriguez; Y Zhang; K Manson; C Bergman; L Rivas; J F Rodriguez; K L Lohman; N H Ruddle
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

4.  Amastigote stage-specific monoclonal antibodies against Leishmania major.

Authors:  C L Jaffe; N Rachamim
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

5.  Temperature effects on molecular processes which lead to stage differentiation in Leishmania.

Authors:  M Shapira; J G McEwen; C L Jaffe
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.